Age-related macular degeneration Clinical Trials
Recruiting age-related macular degeneration studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat age-related macular degeneration. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting age-related macular degeneration studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting age-related macular degeneration trials
Feasibility Study of a Remote Behavioral Dietary Intervention in Patients With Early to Intermediate AMD: Glucose Lowering for Vision Extension
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
User-centric Study of Patients' Receptiveness Towards the Web-based Automated Vision Impairment Gaze-tracking Analysis Systems
Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression
Preparation of Patient Autologous Induced Pluripotent Stem Cell-derived Retinal Cells for AMD
AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study
The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma
Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression
Visual Frailty in Ageing
Adjunct Episcleral Brachytherapy for PCV
Personalised Monitoring of Early and Intermediate Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression
Defining Retinal Structures Using Hyperspectral Retinal Imaging
Evaluation of Clinical Progression, Prognostic Factors, and Quality of Life in Patients with Age-related Macular Degeneration.
Personalized Shared Eye-care Identification of Age-related Macular Degeneration Using Artificial Intelligence and Telemedicine by Matching Optometrist Office-based Sites With Clinical Supervision
Impact of Age-related Macular Degeneration on Daily Living Activitie
Safety and Tolerability of KH658 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - SUMMIT (Part 2)
Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.
Developing and Testing a Model to Identify Preventive Vision Loss Among Older Patients in General Practice
Effects of Goji vs. Fiber on Macular Degeneration
Multicenter Real-life Observational Study Switched Aflibercept or Ranibizumab to Faricimab in Patients With AMD.
Lutein, Zeaxathin, and Fish Oil Supplementation
Progression of Early Atrophic Lesions
Direct Discrimination of Quantum States by the Human Eye
Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration
Expressive Arts-based Intervention for Adults With Age-related Visual Impairment
Photobiomodulation in Dry Age Related Macular Degeneration
Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
Photobiomodulation for Dry Age Related Macula Degeneration
Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Visual Remapping to Aid Reading With Field Loss
Adaptive Optics Imaging of Outer Retinal Diseases
Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression
Village-Integrated Eye Worker Trial II
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
Stem Cell Ophthalmology Treatment Study II
High Resolution Retinal Imaging
National Eye Institute Biorepository for Retinal Diseases
Age-related macular degeneration clinical trials — common questions
Are age-related macular degeneration clinical trials free to join?
Yes. Participating in a age-related macular degeneration clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a age-related macular degeneration clinical trial?
Each age-related macular degeneration study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a age-related macular degeneration trial near me?
Use the location controls above. We'll show recruiting age-related macular degeneration trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many age-related macular degeneration trials are recruiting right now?
We're currently tracking roughly 20 recruiting age-related macular degeneration trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.